2m 2m 2m 2m 2m 2m 2m
Staar Surgical (STAA)
NASDAQ
$28.23-$0.26 (-0.91%)
Price as of Jun 03, 2026 4:57 PM EDT- $1.5BMarket Cap
- 66.22%1-Year Change
- Medical Instruments & SuppliesIndustry
Staar Surgical (STAA)
$28.23-$0.26 (-0.91%)
Annual
Quarterly
01/02/2026 | 12/27/2024 | 12/29/2023 | 12/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 239.4M -23.72% | 313.9M -2.64% | 322.4M +13.37% | 284.4M +23.40% | |
Cost of Revenue | 57.0M -23.27% | 74.3M +6.53% | 69.8M +14.35% | 61.0M +17.70% | |
Gross Profit | 182.4M -23.86% | 239.6M -5.17% | 252.7M +13.10% | 223.4M +25.05% | |
Sales and Marketing Expense | 102.5M -5.35% | 108.3M +0.45% | 107.8M +21.36% | 88.9M +32.04% | |
Research and Development Expense | -40.1M -25.79% | -54.0M +21.56% | -44.4M +23.39% | -36.0M +6.26% | |
Depreciation and Amortization Expense | 13,000 0.00% | 13,000 0.00% | 13,000 -53.57% | 28,000 -17.65% | |
Total Operating Expenses | 57.0M -23.27% | 74.3M +6.53% | 69.8M +14.35% | 61.0M +17.70% | |
Operating Profit | -91.7M +627.25% | -12.6M -144.88% | 28.1M -35.85% | 43.8M +31.38% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 9.4M +165.52% | 3.6M -36.44% | 5.6M +219.94% | 1.8M +186.00% | |
Income before Taxes | -82.3M +808.78% | -9.1M -126.86% | 33.7M -26.03% | 45.6M +45.51% | |
Income Taxes | -1.8M -116.27% | 11.2M -9.66% | 12.3M +81.68% | 6.8M -0.09% | |
Extraordinary Items | 2.8M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -80.4M +298.10% | -20.2M -194.66% | 21.3M -44.92% | 38.8M +58.18% | |
Net Income from Continuing Operations Applicable to Common | -82.3M +808.78% | -9.1M -126.86% | 33.7M -26.03% | 45.6M +45.51% | |
Basic EPS and Net Income | -1.62 +295.12% | -0.41 -193.18% | 0.44 -45.68% | 0.81 +55.77% | |
Diluted EPS and Net Income | -1.62 +295.12% | -0.41 -195.35% | 0.43 -44.87% | 0.78 +56.00% | |
Basic Weighted Average Shares | 49.6M +0.90% | 49.1M +1.24% | 48.5M +1.12% | 48.0M +1.65% | |
Diluted Weighted Average Shares | 49.6M +0.90% | 49.1M -0.61% | 49.4M +0.10% | 49.4M -0.15% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 153.2M +6.24% | 144.2M -21.24% | 183.0M +111.65% | 86.5M -56.70% | |
Short-Term Investments | 34.4M -60.17% | 86.3M +129.08% | 37.7M -69.89% | 125.2M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 187.5M -18.64% | 230.5M +4.43% | 220.7M +4.29% | 211.6M +5.98% | |
Total Current Assets | 311.5M -15.33% | 367.9M +0.73% | 365.3M +17.18% | 311.7M +14.85% | |
Accumulated Depreciation | 39.6M +17.73% | 33.6M +20.89% | 27.8M -26.61% | 37.9M +10.35% | |
Property and Plant and Equipment and Net | 73.3M -13.62% | 84.9M +27.01% | 66.8M +31.25% | 50.9M +41.79% | |
Total Long-Term Assets | 1.4M -92.17% | 17.2M +416.14% | 3.3M +248.90% | 957,000 +16.42% | |
Total Assets | 451.7M -11.35% | 509.5M +4.26% | 488.7M +17.79% | 414.9M +19.99% | |
Income Taxes Payable | 297,000 0.00% | 297,000 -72.42% | 1.1M -27.67% | 1.5M +83.60% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 68.5M -2.56% | 70.3M +8.10% | 65.0M +25.76% | 51.7M +5.97% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 33.2M -6.32% | 35.4M +5.43% | 33.6M +11.51% | 30.1M +0.75% | |
Total Liabilities | 107.5M -4.18% | 112.2M +9.20% | 102.7M +24.22% | 82.7M -5.18% | |
Retained Earnings | -148.0M +119.05% | -67.6M +42.66% | -47.4M -34.79% | -72.6M -34.79% | |
Total Stockholders Equity | 344.2M -13.38% | 397.3M +2.95% | 386.0M +16.18% | 332.2M +28.48% | |
Total Shares Outstanding | 49.4M +0.22% | 49.3M +0.93% | 48.8M +1.30% | 48.2M +1.04% | |
Cash Flow | |||||
Cash from Operating Activities | -34.2M -317.68% | 15.7M +7.75% | 14.6M -59.14% | 35.7M -18.76% | |
Capital Expenditures | 5.8M -75.12% | 23.4M +28.62% | 18.2M +0.44% | 18.1M +32.71% | |
Cash from Investing Activities | 46.3M +178.25% | -59.2M -179.65% | 74.3M +147.54% | -156.4M +1,046.03% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -4.6M -179.58% | 5.7M -22.81% | 7.4M -10.63% | 8.3M -53.37% | |
Financials Ratio | |||||
Gross Margin | 76.19% -0.18% | 76.32% -2.60% | 78.36% -0.24% | 78.55% N/A | |
Operating Margin | -38.30% +853.40% | -4.02% -146.10% | 8.71% -43.42% | 15.40% N/A | |
Return on Assets | -16.74% +313.43% | -4.05% -185.69% | 4.72% -53.63% | 10.19% N/A | |
Return on Equity | -21.70% +320.52% | -5.16% -186.79% | 5.95% -54.69% | 13.12% N/A | |
Revenue Growth | -23.72% +798.27% | -2.64% -119.75% | 13.37% -42.85% | 23.40% N/A | |
Current Ratio | 4.55 -13.10% | 5.23 -6.82% | 5.62 -6.82% | 6.03 N/A | |
Cash Ratio | 2.24 +9.03% | 2.05 -27.14% | 2.81 +68.31% | 1.67 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow